Thu 26 Nov 2009 | 0:48 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Osiris Therapeutics Inc

Osiris Therapeutics Inc (OSIR.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View OSIR on other exchanges
As of  25 Nov 2009
6.50USD
Price Change
-0.02
Percent Change
-0.31%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Debrabandere, Lode 43 2006 Vice President, General Manager - Inflammatory Diseases
Williams, Michelle 34 2007 Vice President - Development
Mills, C. Randall 37 2004 President, Chief Executive Officer, Director
Gutzwiller, Felix 61 2003 Director
Moyes, Jay 55 2006 Director
Barnhill, Gregory 55 2006 Director
Jacoby, Philip 57 2009 Chief Financial Officer, Vice President - Finance, PAO, Corporate Secretary
Friedli, Peter 55 -- Chairman of the Board